Back
California Resources 10K Form
Sell
39
CRC
California Resources
Last Price:
58.50
Seasonality Move:
-10.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | CRC/California Resources Quarterly |
2023-08-01 | 10Q | CRC/California Resources Quarterly |
2023-05-02 | 10Q | CRC/California Resources Quarterly |
2022-11-07 | 10Q | CRC/California Resources Quarterly |
2022-08-04 | 10Q | CRC/California Resources Quarterly |
2022-05-05 | 10Q | CRC/California Resources Quarterly |
Receive CRC News And Ratings
See the #1 stock for the next 7 days that we like better than CRC
CRC Financial Statistics
Sales & Book Value
Annual Sales: | $2.81B |
---|---|
Cash Flow: | $220M |
Price / Cash Flow: | 8.37 |
Annual Sales: | $39.13 |
Price / Book: | 1.55 |
Profitability
EPS (TTM): | 6.35000 |
---|---|
Net Income (TTM): | $531M |
Gross Margin: | $1.41B |
Return on Equity: | 22.28% |
Return on Assets: | 11.31% |
California Resources Earnings Forecast
Key California Resources Financial Ratios
- The Gross Profit Margin over the past 12 years for CRC is 49.95%.
- The Selling, General & Administrative Expenses for CRC have been equal to 9.49% of Gross Profit Margin.
- The Interest Expense is 9.93% of Operating Income.
- The Net Earning history of CRC is 20.05% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 6 years.
California Resources Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Oil, Gas & Consumable Fuels |
Sector: | Energy |
Current Symbol: | CRC |
CUSIP: | 13057Q |
Website: | crc.com |
Debt
Debt-to-Equity Ratio: | 0.32 |
---|---|
Current Ratio: | 0.97 |
Quick Ratio: | 0.71 |
Price-to-Earnings
Trailing P/E Ratio: | 7.61 |
---|---|
Forward P/E Ratio: | 13.01 |
CRC Technical Analysis vs Fundamental Analysis
Sell
39
California Resources (CRC)
is a Sell
Is California Resources a Buy or a Sell?
-
California Resources stock is rated a Sell
The current California Resources [CRC] share price is $59.24. The Score for CRC is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.